ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry

Host cell proteins (HCPs) must be adequately removed from recombinant therapeutics by downstream processing to ensure patient safety, product quality, and regulatory compliance. HCP process clearance is typically monitored by enzyme-linked immunosorbent assay (ELISA) using a polyclonal reagent. Rece...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :MAbs
Главные авторы: Henry, Scott M., Sutlief, Elissa, Salas-Solano, Oscar, Valliere-Douglass, John
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2017
Предметы:
Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5627587/
https://ncbi.nlm.nih.gov/pubmed/28708446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2017.1349586
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы